{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:13:35Z","timestamp":1777439615073,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Research Foundation of Beijing Friendship Hospital, Capital Medical University","award":["No. yyqdkt2016-9"],"award-info":[{"award-number":["No. yyqdkt2016-9"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10067-018-04418-9","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T05:06:22Z","timestamp":1547528782000},"page":"1425-1431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Serum-soluble TRAIL: a potential biomarker for disease activity in myositis patients"],"prefix":"10.1007","volume":"38","author":[{"given":"Hang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuju","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"issue":"9388","key":"4418_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362(9388):971\u2013982","journal-title":"Lancet"},{"issue":"2","key":"4418_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2010.1977","volume":"305","author":"LG Rider","year":"2011","unstructured":"Rider LG, Miller FW (2011) Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 305(2):183\u2013190","journal-title":"JAMA"},{"issue":"1","key":"4418_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12016-016-8527-x","volume":"52","author":"A Ceribelli","year":"2017","unstructured":"Ceribelli A, De Santis M, Isailovic N, Gershwin ME, Selmi C (2017) The immune response and the pathogenesis of idiopathic inflammatory myositis: a critical review. Clin Rev Allergy Immunol 52(1):58\u201370","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"4418_CR4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/annrheumdis-2013-205127","volume":"74","author":"C Dobloug","year":"2015","unstructured":"Dobloug C, Garen T, Bitter H, Stj\u00e4rne J, Stenseth G, Gr\u00f8vle L, Sem M, Gran JT, Molberg \u00d8 (2015) Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis 74(8):1551\u20131556","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4418_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/08916930600622173","volume":"39","author":"G Chevrel","year":"2006","unstructured":"Chevrel G, Page G, Miossec P (2006) Novel aspects on the contribution of T cells and dendritic cells in the pathogenesis of myositis. Autoimmunity 39(3):171\u2013176","journal-title":"Autoimmunity"},{"issue":"53","key":"4418_CR6","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","volume":"22","author":"S Wang","year":"2003","unstructured":"Wang S, El-Deiry WS (2003) TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22(53):8628\u20138633","journal-title":"Oncogene"},{"issue":"1","key":"4418_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","volume":"10","author":"HN LeBlanc","year":"2003","unstructured":"LeBlanc HN, Ashkenazi A (2003) Apo2L\/TRAIL and its death and decoy receptors. Cell Death Differ 10(1):66\u201375","journal-title":"Cell Death Differ"},{"issue":"1","key":"4418_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10495-005-6060-0","volume":"10","author":"S Bouralexis","year":"2005","unstructured":"Bouralexis S, Findlay DM, Evdokiou A (2005) Death to the bad guys: targeting cancer via Apo2L\/TRAIL. Apoptosis 10(1):35\u201351","journal-title":"Apoptosis"},{"issue":"11","key":"4418_CR9","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.bcp.2011.12.036","volume":"83","author":"L Martinez-Lostao","year":"2012","unstructured":"Martinez-Lostao L, Marzo I, Anel A, Naval J (2012) Targeting the Apo2L\/TRAIL system for the therapy of autoimmune diseases and cancer. Biochem Pharmacol 83(11):1475\u20131483","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"4418_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10067-012-2023-3","volume":"31","author":"NA Azab","year":"2012","unstructured":"Azab NA, Rady HM, Marzouk SA (2012) Elevated serum TRAIL levels in scleroderma patients and its possible association with pulmonary involvement. Clin Rheumatol 31(9):1359\u20131364","journal-title":"Clin Rheumatol"},{"issue":"3","key":"4418_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni894","volume":"4","author":"SE Lamhamedi-Cherradi","year":"2003","unstructured":"Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH (2003) Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL\u2212\/\u2212 mice. Nat Immunol 4(3):255\u2013260","journal-title":"Nat Immunol"},{"issue":"11","key":"4418_CR12","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1002\/art.30530","volume":"63","author":"HM Alger","year":"2011","unstructured":"Alger HM, Raben N, Pistilli E, Francia DL, Rawat R, Getnet D, Ghimbovschi S, Chen YW, Lundberg IE, Nagaraju K (2011) The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage. Arthritis Rheum 63(11):3448\u20133457","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4418_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.clim.2007.06.011","volume":"125","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Fedczyna TO, McVicker V, Caliendo J, Li H, Pachman LM (2007) Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease. Clin Immunol 125(2):165\u2013172","journal-title":"Clin Immunol"},{"issue":"3\u20134","key":"4418_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1359-6101(03)00029-7","volume":"14","author":"A Almasan","year":"2003","unstructured":"Almasan A, Ashkenazi A (2003) Apo2L\/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14(3\u20134):337\u2013348","journal-title":"Cytokine Growth Factor Rev"},{"issue":"7","key":"4418_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347","journal-title":"N Engl J Med"},{"issue":"8","key":"4418_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u2013407","journal-title":"N Engl J Med"},{"issue":"1","key":"4418_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Vencovsky J, Cooper R, Rider L, Miller F, International Myositis and Clinical Studies Group (IMACS) (2004) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 43(1):49\u201354","journal-title":"Rheumatology (Oxford)"},{"key":"4418_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2377-11-143","volume":"11","author":"XM Shu","year":"2011","unstructured":"Shu XM, Lu X, Xie Y, Wang GC (2011) Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China. BMC Neurol 11:143","journal-title":"BMC Neurol"},{"issue":"6","key":"4418_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/ard.2004.029058","volume":"64","author":"MN Lub-de Hooge","year":"2005","unstructured":"Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M (2005) Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis 64(6):854\u2013858","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4418_CR20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3899\/jrheum.091363","volume":"37","author":"P Secchiero","year":"2010","unstructured":"Secchiero P, Corallini F, Castellino G, Bortoluzzi A, Caruso L, Bugatti S et al (2010) Baseline serum concentrations of TRAIL in early rheumatoid arthritis: relationship with response to disease-modifying antirheumatic drugs. J Rheumatol 37(7):1461\u20131466","journal-title":"J Rheumatol"},{"issue":"4","key":"4418_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1084\/jem.20041367","volume":"201","author":"L Casciola-Rosen","year":"2005","unstructured":"Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, Corse A, Rosen A (2005) Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 201(4):591\u2013601","journal-title":"J Exp Med"},{"issue":"1","key":"4418_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","volume":"73","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman DP, Oddis CV (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 73(1):227\u2013232","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4418_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/art.20038","volume":"50","author":"HF Tsai","year":"2004","unstructured":"Tsai HF, Lai JJ, Chou AH, Wang TF, Wu CS, Hsu PN (2004) Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus. Arthritis Rheum 50(2):629\u2013639","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-04418-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-04418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-04418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T09:34:53Z","timestamp":1580722493000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-04418-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4418"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-04418-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]},"assertion":[{"value":"13 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Beijing Friendship Hospital (approved number: 2018-P2-204-01). Informed consent was obtained from all enrolled participants for their data to be used for this study. Patients did not receive any financial compensation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}